Elegant Hoopoe's Longevity Scores Pave Way for Accessible Preventive Healthcare

The biohacking industry is rapidly expanding, with projections reaching $108.57 billion by 2029. Elegant Hoopoe is leading the charge in integrating longevity science into mainstream healthcare through personalized "longevity scores". This 12-week program evaluates 56 biomarkers to provide tailored health insights, moving beyond niche trends to accessible preventive medicine globally. Having already administered over 30,000 treatments in the UAE, the company is accelerating its growth across North America and Europe.

CEO Shahriar Shahir Barzegar emphasizes the democratisation of health optimisation, offering elite-level precision at affordable prices. Central to their model is the SEGA™ platform, which combines biomarker data with wearable technology to yield actionable insights across stress, sleep, and metabolism. Notably, clients have reported significant health improvements, such as a reversed biological age within just eight weeks.